Patents by Inventor Nobuo Yokoo

Nobuo Yokoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4755383
    Abstract: A pharmaceutical composition is disclosed which comprises a physiologically active substance possessing peptide bonds in its structure and being inactivable by digestive enzymes, the active substances being other than insulin, and a synthetic chymotrypsin inhibitor. The composition is particularly suitable for intestinal absorption of the active substance.
    Type: Grant
    Filed: June 30, 1986
    Date of Patent: July 5, 1988
    Assignee: Kowa Co., Ltd.
    Inventors: Setsuro Fujii, Touru Yokoyama, Kouji Ikegaya, Nobuo Yokoo, Masahiko Nagakura
  • Patent number: 4746737
    Abstract: Novel benzoyl esters of the following formula (I), and acid addition salts thereof, ##STR1## in which R.sub.1 and R.sub.2 are the same or different and represent a hydrogen atom or a lower alkoxy group, A represents a single bond, a linear or branched lower alkylene group, a lower alkenylene group, R.sub.3 and R.sub.4 are the same or different and represent a hydrogen atom or a lower alkyl group, or R.sub.3 and R.sub.4 join together to form a lower alkylene group, R.sub.5 represents a group of the formula, --X--(CO).sub.
    Type: Grant
    Filed: July 16, 1986
    Date of Patent: May 24, 1988
    Assignee: Kowa Co., Ltd.
    Inventors: Setsuro Fujii, Eizou Hattori, Mitsuteru Hirata, Koichiro Watanabe, Tomio Ohta, Nobuo Yokoo, Masahiko Nagakura
  • Patent number: 4639435
    Abstract: A pharmaceutical composition is disclosed which comprises a physiologically active substance possessing peptide bonds in its structure and being inactivable by digestive enzymes, the active substance being other than insulin, and a synthetic chymotrypsin inhibitor. The composition is particularly suitable for intestinal absorption of the active substance.
    Type: Grant
    Filed: June 27, 1984
    Date of Patent: January 27, 1987
    Assignee: Kowa Co., Ltd.
    Inventors: Setsuro Fujii, Touru Yokoyama, Kouji Ikegaya, Nobuo Yokoo, Masahiko Nagakura
  • Patent number: 4256631
    Abstract: The specification describes an economical process for the preparation of immunoglobulin for intravenous administration. An immunoglobulin can be, in accordance with the process, purified by a combination of a fractional precipitation method and an affinity chromatography. As a precipitant, divalent or trivalent metal salts are used and a complex of human IgG and a polyhydroxy polymeric compound is employed as an adsorbent. Purified immunoglobulin contains little or no aggregated or partially denatured globulin which is believed to cause anaphylaxis when administered intravenously. Prior art techniques cannot economically provide immunoglobulin in such a purified form and only intramuscular injections were feasible. Intravenous administrations allow immunoglobulin to be dosed in a larger amount and to act much faster than intramuscular injections.
    Type: Grant
    Filed: March 18, 1980
    Date of Patent: March 17, 1981
    Assignee: Kowa Company, Limited
    Inventors: Nobuo Yokoo, Toshihito Mori